UTHR United Therapeutics Corporation

$497.11▼ -1.34% Healthcare Other
After hours $497.11▲ +0.00% Sep 11, 7:30 PM ET
Volume 359.4K Avg Volume (10D) 545.9K
Key Metrics & Fundamentals
Market Cap
$21.32B
P/E Ratio
17.8
Div Yield
–%
52W Range
396.12 - 609.35
% vs 50 MA
-4.82%
% vs 200 MA
-5.13%
RSI-14
42.1
MACD Histogram
-0.4300
Beta (1Y vs SPY)
0.26
Free Cash Flow
$205.60M
Gross Rev
$783.30M
Gross Profit
$683.80M
EBITDA
$399.80M
COGS
$99.50M
Operating Exp
$353.00M
Operating Income
$330.80M
EBIT
$330.80M
Pretax Income
$372.70M
Net Income
$333.00M
EPS (Diluted)
7.27
Price & Volume History
Loading chart…
Recent News
United Therapeutics Insider Sold Shares Worth $4,772,295, According to a Recent SEC Filing
MT Newswires · Sep 11, 2026 8:38 PM
1 Cash-Heavy Stock to Target This Week and 2 We Question
StockStory · Sep 11, 2026 6:51 PM
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Zacks · Sep 11, 2026 6:21 PM
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
Zacks · Sep 11, 2026 3:30 PM
United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace?
Insider Monkey · Sep 11, 2026 12:21 AM
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
Zacks · Sep 10, 2026 5:38 PM
United Therapeutics Insider Sold Shares Worth $4,740,795, According to a Recent SEC Filing
MT Newswires · Sep 9, 2026 8:37 PM
Therapeutics Stocks Q2 Teardown: United Therapeutics (NASDAQ:UTHR) Vs The Rest
StockStory · Sep 9, 2026 8:10 PM
United Therapeutics Insider Sold Shares Worth $4,647,354, According to a Recent SEC Filing
MT Newswires · Sep 8, 2026 8:40 PM
United Therapeutics to Repurchase $478 Million of Shares
MT Newswires · Sep 8, 2026 11:48 AM
Financial Overview - Income Statement Quarterly

See UTHR's money flow as a full page

Social Sentiment
Avg +0.26 · 11 posts
NewsTradePriceTargetMarket Close Report - Monday, March 30, 2026
r/investing · Mar 30, 2026
Significant positive movement reported, indicating strong investor interest.
very_positive +1.00
DDNewsTrade$LQDA DeepDive. $3B marketcap looks incredibly cheap..
r/wallstreetbets · Jan 14, 2026
Comparative analysis of Tyvaso, highlighting potential growth.
positive +0.70
TradeDiscussionI’m tired of all this biotechs! Heavy short on $UTHR
r/wallstreetbets · Dec 22, 2025
The user expresses frustration and announces a short position, indicating a bearish sentiment towards the stock.
negative -0.60
UTHR: FCF Undervalued Biotech King (-16% Today)
r/stocks · Jun 10, 2025
The post highlights UTHR's strong FCF, low P/E ratio, and potential upside, indicating a bullish outlook.
positive +0.60
NewsDiscussionTradeLQDA Bullish Play
r/wallstreetbets · May 20, 2025
UTHR's exclusivity patent is presented as a hurdle to LQDA's approval, creating a negative sentiment.
negative -0.40
Page 1 of 3 (11 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙